Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism.

Somayyeh HashemianReza Jafarzadeh EsfehaniSiroos KarimdadiRahim VakiliDaniel ZamanfarAmir Hossein Sahebkar

Published in: International journal of endocrinology (2020)

This study suggested that sirolimus therapy needs further evaluation to determine which patients will benefit the most. The genetic basis of CHI may have possible implications for determining the patient's response.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
case report
genome wide
stem cells
gene expression
smoking cessation